direct peptide reactivity assay to assess chemical ingredients used in cosmetics - KeratinoSensassay identifies dermal sensitizers Understanding the Direct Peptide Reactivity Assay (DPRA) for Skin Sensitization Assessment

DirectPeptides retatrutide The Direct Peptide Reactivity Assay (DPRA) is a crucial in chemico method employed in the scientific community to assess the potential of chemicals to cause skin sensitization. This assay is recognized as an OECD test guideline method, specifically OECD 442C, and plays a significant role in understanding the initial steps of the skin sensitization process. By focusing on the reactivity of chemicals, the DPRA offers a valuable non-animal approach to identifying dermal sensitizersKinetic Direct Peptide Reactivity Assay (kDPRA, OECD ....

At its core, the Direct Peptide Reactivity Assay (DPRA) addresses the first molecular key event of the adverse outcome pathway (AOP) for skin sensitization, which is protein reactivity or haptenation. This means the assay is designed to mimic how a chemical might interact with proteins in the skin, a critical step in triggering an allergic reaction. The assay examines the first molecular key event of haptenation by measuring the depletion of specific peptides when exposed to a test chemical.Direct Pep de Reac vity Assay (DPRA) This provides insight into whether a substance is likely to bind covalently to skin proteins, a process known as haptenation, which is a prerequisite for skin sensitization.

How the DPRA Works: Peptides and Reactivity

The methodology of the Direct Peptide Reactivity Assay (DPRA) relies on the use of model peptides that contain specific amino acid residues susceptible to reaction with electrophilic chemicals.The in chemico direct peptide reactivity assay (DPRA)addresses the first molecular key event of the adverse outcome pathway(AOP) of skin sensitization.1 ... These are typically two types of peptides, one containing cysteine and another containing lysine. These amino acids possess nucleophilic side chains that can react with chemicals that are electrophilic. The assay works by incubating a test chemical with these peptides and then quantifying the amount of peptide that remains after a set incubation period. A significant depletion of the peptide indicates that the chemical has reacted with it, suggesting a potential for skin sensitization.

Specifically, the assay measures peptide reactivity of test chemicals by quantifying the loss of these peptides. The DPRA utilizes two model peptides to cover a broader range of potential interactions. One peptide contains cysteine residues, and the other contains lysine residues. The reaction is typically carried out over a 24-hour period. The principle behind this is that if a chemical is a sensitizer, it will react with these amino acid residues, leading to a decrease in the concentration of the free peptide.This Test Guideline is proposed to address the Molecular Initiating Event leading to skin sensitisation, namely proteinreactivity, by quantifying the ... This decrease is then measured, often using spectrophotometric methods, to determine the extent of the reaction.

The DPRA is considered a major advance in characterization of sensitizing elements because it directly assesses the intrinsic reactivity of a substance, which is a fundamental driver of skin sensitizationSkin sensitisation: the Direct Peptide Reactivity Assay (DPRA). The assay quantifies the remaining concentration of cysteine- or lysine-containing peptide after incubation, providing a direct measure of the chemical's reactivityThis Test Guideline is proposed to address the Molecular Initiating Event leading to skin sensitisation, namely proteinreactivity, by quantifying the .... Furthermore, this test assesses multiple substance concentrations and time points in some variations, allowing for a more detailed understanding of the dose- and time-dependent reactivity.

The Role of DPRA in Safety Assessment

The Direct Peptide Reactivity Assay (DPRA) is a valuable tool for regulatory bodies and industries when evaluating the safety of chemicals, particularly those used in consumer products. It is a key component in a tiered testing strategy for skin sensitization. The assay identifies dermal sensitizers by providing evidence of a chemical's ability to interact with skin proteins. This information is crucial for risk assessment and for ensuring that products placed on the market do not pose an undue risk to consumersPeptide reactivity assays for skin sensitisation.

The GLP Direct Peptide Reactivity Assay (DPRA), when conducted under Good Laboratory Practice (GLP) standards, ensures the reliability and reproducibility of the results, making them suitable for submission to regulatory authoritiesPre-validation study of spectrophotometric direct peptide .... The assay tests chemicals for their ability to react with protein and is used as a screening tool to prioritize chemicals for further testing or to rule out sensitization potential. This is particularly important for assessing chemical ingredients used in cosmetics, where direct human exposure is common.

The DPRA is recognized as one of three test methods that form part of an integrated approach to testing and assessment (IATA) for skin sensitization. The other methods often include *in vitro* assays like KeratinoSens™ and the human Cell Line Activation Test (h-CLAT). The combined data from these different assays provides a more comprehensive picture of a chemical's sensitization potential than any single test alone.

Advancements and Variations of the DPRA

While the standard DPRA provides valuable information, advancements have led to variations such as the kinetic DPRA assay (kDPRA). The kinetic DPRA assay builds upon the original assay by measuring the rate of peptide depletion over time, providing more quantitative reaction data. This allows for a better understanding of the kinetics of the reaction and can help in predicting the potency of a sensitizerDirect Peptide Reactivity Assay (DPRA, OECD 442C). The kDPRA can investigate skin sensitization potency by measuring the kinetic rates of cysteine peptide depletion.

The Direct Peptide Reactivity Assay (DPRA) is a sophisticated in chemico technique that recapitulates the first key event within the skin sensitization adverse outcome pathway. Its ability to directly measure the reactivity between chemicals and model peptides makes it a powerful predictive tool.In Chemico Skin Sensitisation: Direct Peptide Reactivity ... By providing verifiable information on a chemical's potential to haptenate proteins, the DPRA contributes significantly to the development of safer chemicals and consumer products. The assay determines the reactivity between chemicals and peptides by defining a peptide depletion compared to a vehicle control作者：JA Seo·2022·被引用次数：7—This assaydetermines the reactivity between chemicals and peptidesby defining a peptide depletion (compared to a vehicle control) using high- .... This measured reactivity is a key indicator for potential skin sensitization.